These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33492618)

  • 1. An Evaluation of the Fecal Microbiome in Lynch Syndrome.
    Gonzalez A; Kapila N; Melendez-Rosado J; Liang H; Castro-Pavia F
    J Gastrointest Cancer; 2021 Mar; 52(1):365-368. PubMed ID: 33492618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiome Composition in Lynch Syndrome With and Without History of Colorectal Neoplasia and Non-Lynch Controls.
    Rifkin SB; Sze MA; Tuck K; Koeppe E; Stoffel EM; Schloss PD
    J Gastrointest Cancer; 2024 Mar; 55(1):207-218. PubMed ID: 37310549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbial signatures are associated with Lynch syndrome (LS) and cancer history in Druze communities in Israel.
    Naddaf R; Carasso S; Reznick-Levi G; Hasnis E; Qarawani A; Maza I; Gefen T; Half EE; Geva-Zatorsky N
    Sci Rep; 2023 Nov; 13(1):20677. PubMed ID: 38001152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the Mucosal and Stool Microbiome in Lynch Syndrome.
    Yan Y; Drew DA; Markowitz A; Lloyd-Price J; Abu-Ali G; Nguyen LH; Tran C; Chung DC; Gilpin KK; Meixell D; Parziale M; Schuck M; Patel Z; Richter JM; Kelsey PB; Garrett WS; Chan AT; Stadler ZK; Huttenhower C
    Cell Host Microbe; 2020 Apr; 27(4):585-600.e4. PubMed ID: 32240601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gynecological surveillance of women with Lynch syndrome in Sweden.
    Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
    Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.
    Walsh CS; Blum A; Walts A; Alsabeh R; Tran H; Koeffler HP; Karlan BY
    Gynecol Oncol; 2010 Mar; 116(3):516-21. PubMed ID: 20034658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
    Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
    Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS).
    Zeimet AG; Mori H; Petru E; Polterauer S; Reinthaller A; Schauer C; Scholl-Firon T; Singer C; Wimmer K; Zschocke J; Marth C
    Arch Gynecol Obstet; 2017 Jul; 296(1):123-127. PubMed ID: 28510097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
    Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
    JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicalpathological characteristics of Lynch syndrome related epithelial ovarian cancer].
    Ma XG; Wang YM; Xue FX; Zhang HY; Sheng HN; Qi Z; Liu GY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):201-4. PubMed ID: 22781072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
    Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
    Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical features and management of Lynch syndrome-associated ovarian cancer.
    Ran X; Jing H; Li Z
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1538-1545. PubMed ID: 35478369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancers.
    Yamada A; Doi Y; Minamiguchi S; Kondo T; Sunami T; Horimatsu T; Hamanishi J; Mandai M; Hatano E; Kobayashi T; Hisamori S; Obama K; Seno H; Haga H; Torishima M; Murakami H; Nakajima T; Yamada T; Kosugi S; Sugano K; Muto M
    Int J Clin Oncol; 2024 Nov; 29(11):1696-1703. PubMed ID: 39187737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer.
    Takahashi K; Sato N; Sugawara T; Kato A; Sato T; Shimizu D; Tamura D; Kito M; Makino K; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Terada Y
    Gynecol Oncol; 2017 Nov; 147(2):388-395. PubMed ID: 28847642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
    Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
    Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immediate germline sequencing and multi-step screening for Lynch syndrome detection in high-risk endometrial and colorectal cancer patients.
    Chao AS; Chao A; Lai CH; Lin CY; Yang LY; Chang SC; Wu RC
    J Gynecol Oncol; 2024 Jan; 35(1):e5. PubMed ID: 37743058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome.
    Lang M; Baumgartner M; Rożalska A; Frick A; Riva A; Jarek M; Berry D; Gasche C
    Int J Cancer; 2020 Oct; 147(8):2316-2326. PubMed ID: 32350866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.
    Lincoln A; Benton S; Piggott C; North BV; Rigney J; Young C; Quirke P; Sasieni P; Monahan KJ
    BMC Cancer; 2022 Nov; 22(1):1144. PubMed ID: 36344941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.